KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 161 filers reported holding KITE PHARMA INC in Q3 2015. The put-call ratio across all filers is 0.60 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $247,676,000 | +38.5% | 1,377,399 | -20.1% | 0.02% | +31.2% |
| Q2 2017 | $178,785,000 | +51.6% | 1,724,567 | +14.8% | 0.02% | +45.5% |
| Q1 2017 | $117,942,000 | +33.7% | 1,502,672 | -23.6% | 0.01% | +37.5% |
| Q4 2016 | $88,217,000 | -0.3% | 1,967,213 | +24.2% | 0.01% | -11.1% |
| Q3 2016 | $88,454,000 | +23.6% | 1,583,520 | +10.6% | 0.01% | +12.5% |
| Q2 2016 | $71,557,000 | +17.0% | 1,431,129 | +7.4% | 0.01% | +14.3% |
| Q1 2016 | $61,162,000 | -2.7% | 1,332,147 | +30.6% | 0.01% | 0.0% |
| Q4 2015 | $62,831,000 | +24.7% | 1,019,666 | +12.7% | 0.01% | +16.7% |
| Q3 2015 | $50,387,000 | -5.1% | 904,951 | +4.0% | 0.01% | 0.0% |
| Q2 2015 | $53,069,000 | +82.8% | 870,492 | +73.0% | 0.01% | +100.0% |
| Q1 2015 | $29,024,000 | +322.2% | 503,218 | +322.1% | 0.00% | +200.0% |
| Q4 2014 | $6,874,000 | +234.5% | 119,208 | +65.3% | 0.00% | – |
| Q3 2014 | $2,055,000 | – | 72,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|